Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792414950> ?p ?o ?g. }
- W2792414950 endingPage "2063" @default.
- W2792414950 startingPage "2048" @default.
- W2792414950 abstract "Immunotherapy prolongs survival in only a subset of melanoma patients, highlighting the need to better understand the driver tumor microenvironment. We conducted bioinformatic analyses of 703 transcriptomes to probe the immune landscape of primary cutaneous melanomas in a population-ascertained cohort. We identified and validated 6 immunologically distinct subgroups, with the largest having the lowest immune scores and the poorest survival. This poor-prognosis subgroup exhibited expression profiles consistent with β-catenin–mediated failure to recruit CD141+ DCs. A second subgroup displayed an equally bad prognosis when histopathological factors were adjusted for, while 4 others maintained comparable survival profiles. The 6 subgroups were replicated in The Cancer Genome Atlas (TCGA) melanomas, where β-catenin signaling was also associated with low immune scores predominantly related to hypomethylation. The survival benefit of high immune scores was strongest in patients with double-WT tumors for BRAF and NRAS, less strong in BRAF-V600 mutants, and absent in NRAS (codons 12, 13, 61) mutants. In summary, we report evidence for a β-catenin–mediated immune evasion in 42% of melanoma primaries overall and in 73% of those with the worst outcome. We further report evidence for an interaction between oncogenic mutations and host response to melanoma, suggesting that patient stratification will improve immunotherapeutic outcomes." @default.
- W2792414950 created "2018-03-29" @default.
- W2792414950 creator A5000110195 @default.
- W2792414950 creator A5003708582 @default.
- W2792414950 creator A5012814808 @default.
- W2792414950 creator A5018344543 @default.
- W2792414950 creator A5021151597 @default.
- W2792414950 creator A5024023567 @default.
- W2792414950 creator A5027879841 @default.
- W2792414950 creator A5044801113 @default.
- W2792414950 creator A5050210678 @default.
- W2792414950 creator A5054489737 @default.
- W2792414950 creator A5054607383 @default.
- W2792414950 creator A5064084123 @default.
- W2792414950 creator A5065344551 @default.
- W2792414950 creator A5077205401 @default.
- W2792414950 creator A5079874107 @default.
- W2792414950 creator A5080449721 @default.
- W2792414950 creator A5081844624 @default.
- W2792414950 creator A5090210646 @default.
- W2792414950 date "2018-04-16" @default.
- W2792414950 modified "2023-10-17" @default.
- W2792414950 title "β-Catenin–mediated immune evasion pathway frequently operates in primary cutaneous melanomas" @default.
- W2792414950 cites W1498931318 @default.
- W2792414950 cites W1555518714 @default.
- W2792414950 cites W1572739876 @default.
- W2792414950 cites W1768619703 @default.
- W2792414950 cites W1769186443 @default.
- W2792414950 cites W1815698031 @default.
- W2792414950 cites W1863484212 @default.
- W2792414950 cites W1950829641 @default.
- W2792414950 cites W1965037168 @default.
- W2792414950 cites W1965370740 @default.
- W2792414950 cites W1966107523 @default.
- W2792414950 cites W1967954493 @default.
- W2792414950 cites W1969610841 @default.
- W2792414950 cites W1971228613 @default.
- W2792414950 cites W1976199086 @default.
- W2792414950 cites W1977179270 @default.
- W2792414950 cites W1993057815 @default.
- W2792414950 cites W2008229215 @default.
- W2792414950 cites W2021262975 @default.
- W2792414950 cites W2028433016 @default.
- W2792414950 cites W2030612376 @default.
- W2792414950 cites W2062094438 @default.
- W2792414950 cites W2066671159 @default.
- W2792414950 cites W2076184714 @default.
- W2792414950 cites W2083574998 @default.
- W2792414950 cites W2089536793 @default.
- W2792414950 cites W2097288420 @default.
- W2792414950 cites W2097995306 @default.
- W2792414950 cites W2106608030 @default.
- W2792414950 cites W2108026478 @default.
- W2792414950 cites W2110457899 @default.
- W2792414950 cites W2115462905 @default.
- W2792414950 cites W2121071739 @default.
- W2792414950 cites W2123105952 @default.
- W2792414950 cites W2128035403 @default.
- W2792414950 cites W2130430382 @default.
- W2792414950 cites W2133650808 @default.
- W2792414950 cites W2134644618 @default.
- W2792414950 cites W2134878419 @default.
- W2792414950 cites W2136731993 @default.
- W2792414950 cites W2149635248 @default.
- W2792414950 cites W2160381920 @default.
- W2792414950 cites W2184284683 @default.
- W2792414950 cites W2220882815 @default.
- W2792414950 cites W2256549280 @default.
- W2792414950 cites W2307696205 @default.
- W2792414950 cites W2403400382 @default.
- W2792414950 cites W2406250479 @default.
- W2792414950 cites W2414334460 @default.
- W2792414950 cites W2433816729 @default.
- W2792414950 cites W2461271870 @default.
- W2792414950 cites W2507265965 @default.
- W2792414950 cites W2512255557 @default.
- W2792414950 cites W2519279652 @default.
- W2792414950 cites W2529373149 @default.
- W2792414950 cites W2529896336 @default.
- W2792414950 cites W2564004030 @default.
- W2792414950 cites W2613155082 @default.
- W2792414950 cites W2655262992 @default.
- W2792414950 cites W2746148521 @default.
- W2792414950 cites W2752227448 @default.
- W2792414950 cites W2753432434 @default.
- W2792414950 doi "https://doi.org/10.1172/jci95351" @default.
- W2792414950 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5919828" @default.
- W2792414950 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29664013" @default.
- W2792414950 hasPublicationYear "2018" @default.
- W2792414950 type Work @default.
- W2792414950 sameAs 2792414950 @default.
- W2792414950 citedByCount "69" @default.
- W2792414950 countsByYear W27924149502018 @default.
- W2792414950 countsByYear W27924149502019 @default.
- W2792414950 countsByYear W27924149502020 @default.
- W2792414950 countsByYear W27924149502021 @default.
- W2792414950 countsByYear W27924149502022 @default.
- W2792414950 countsByYear W27924149502023 @default.